Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07546331 · ClinicalTrials.gov registry record
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 40
- Enrollment target
NCT07546331: Recruiting study, sponsored by University of California, San Francisco.
NCT07546331 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07546331 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study compares measurements of body composition to outcomes of breast reconstruction.
Primary Outcome
The proportion of enrolled participants with successfully obtained body composition measurements at both preoperative and postoperative timepoints. A success rate of ≥90% will be considered feasible. The proportion of the participants meets feasibility will be reported.
Interventions
- OTHER Chart Review
- PROCEDURE Measurement of Body Composition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-18 |
| Est. Completion | 2028-12-31 |
What NCT07546331 shows while recruiting
NCT07546331 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Chart Review is the first listed.
NCT07546331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07546331 about?
NCT07546331 is a clinical study titled "Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction". This study compares measurements of body composition to outcomes of breast reconstruction.
What is the current status of trial NCT07546331?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2026-02-18. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07546331?
The interventions under investigation include: Chart Review (OTHER), Measurement of Body Composition (PROCEDURE).
Who is sponsoring clinical trial NCT07546331?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI